DHPC reaches healthcare professionals effectively and effortlessly
The Direct Healthcare Professional Communication (DHPC) is a cost-effective and comprehensive way to reach a wide range of healthcare professionals to promote correct and safe use of pharmaceuticals. We transmit authority-approved DHPC communication and important risk management materials on your behalf effectively and effortlessly.
We work together with Lääkärikompassi Oy that is exclusively owned by the Finnish Medical Association (FMA). With our DHPC service you have access to Lääkärikompassi's physicians address database, which includes both e-mails and postal addresses. This reliable database is based on the FMA member register that represents 95 % of physicians living in Finland. The FMA register includes 25 000 postal and 20 00 email addresses.
Physicians and other healthcare professionals consider it important that all communication regarding pharmacovigilance can easily be differentiated from all other material relating to pharmaceuticals. All our DHPC and risk management material, whether delivered via email or post, are hence marked with a clear DHPC logo.
The cornerstones of our service are quality and customer-focus
Reliable distribution partners
Up-to-date contact information
Accurate and timely communication
Easy and straightforward one-stop service
We cover all aspects of DHPC communication:
collecting required address information
printing the letter and/or producing an email version
delivering the letters and emails to a specified target group
Our DHPC service is comprehensive and cost-effective. The pricing is stepwise and depends on the number of recipients, the number of documents delivered by email or post and the number of pages and whether they are coloured or not (concerning postal delivery).
The target group for the DHPC communication is designated by a particular speciality or physicians’ field of expertise. The selection can also be defined by age and place of residence.
We’re happy to help with any aspects of pharmacovigilance!
Contact us as soon as the need to a direct healthcare communication about pharmacovigilance has arisen in a conversation with the authorities. At first, we need to know the subject of the statement, target group and the estimated date for delivery. With this information we can make an offer about the service. The actual DHPC and risk management material can be sent to us closer to the scheduled delivery time.
Send the DHPC and risk management material to our production as a pdf-file. The material can contain the company logo and the signatures of persons in charge. We recommend creating the pdf-file directly from the original file (i.e. not scanned) to ensure high quality printing results.
DHPC communications regarding products with several marketing authorization holders are invoiced equally between each respective company. Following the distribution of the material, we confirm the delivery to the client. We don’t disclose contact information to third parties.